Skip to main content
Article thumbnail
Location of Repository

Analysis of circulating insulin-like growth factor-1 (IGF-1) and IGF binding protein-3 (IGFBP-3) in tobacco smokers and non-smokers

By RM Palmer, RF Wilson, PY Coward and DA Scott
Topics: Research
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:2671651
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. (2001). A cross-sectional study of IGF-I determinants in women.
    2. (2001). A prospective study of insulin-like growth factor-I, IGF-binding proteins-1, -2 and -3 and lung cancer risk in women.
    3. (1990). A rapid gas-liquid chromatographic method for the determination of cotinine and nicotine in biological fluids.
    4. (2001). Are dietary influences on the risk of prostate cancer mediated through the insulin-like growth factor system?
    5. Cigarette smoking exposure, serum insulin-like growth factors, and cancer risk: A population-based study. Endocrine Abstracts 2002: 3:
    6. (2000). Comparison of serum insulin-like growth factor-1 and growth hormone levels in osteoporotic and nonosteoporotic postmenopausal women. Rheumatology International
    7. (1987). Comparison of tests used to distinguish smokers from nonsmokers.
    8. (1999). Dietary fat and carbohydrates are independently associated with circulating insulin-like growth factor 1 and insulin-like growth factor-binding protein 3 concentrations in healthy adults.
    9. (1992). Diverse effects of insulin-like growth factor I on glucose, lipid, and amino acid metabolism.
    10. (1998). Exposure of vascular allografts to insulin-like growth factor-I (IGF-I) increases vascular expression of IGF-I ligand and receptor protein and accelerates arteriosclerosis in rats. Transplantation
    11. (2001). IGF-1, IGF-2 and IGFBP-3 in prediagnostic serum: association with colorectal cancer in a cohort of Chinese men in Shanghai.
    12. (2001). IGFBP-3 and apoptosis--a license to kill? Apoptosis
    13. (1999). Inflammation-related neutrophil proteases, cathepsin G and elastase, function as insulin-like growth factor binding protein proteases.
    14. (1993). Insulin-like growth factor I inhibits glucose-stimulated insulin secretion but does not impair glucose metabolism in normal humans.
    15. (2000). Insulin-like growth factor-binding protein-3 is associated with the presence and extent of coronary arteriosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology
    16. (1996). Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamics.
    17. (1995). Insulin-like growth factors and their binding proteins: biological actions. Endocrine Reviews
    18. (1999). Is the measurement of free IGF-I more indicative than that of total IGF-I in the evaluation of the biological activity of the GH/IGF-I axis?
    19. (2000). Low serum IGF-1 and occurrence of osteoporotic fractures in postmenopausal women. Lancet
    20. (1995). Matrix metalloproteinases as insulin-like growth factor binding protein-degrading proteinases.
    21. Nicotine replacement therapy does not compromise a rapid recovery in circulating adhesion molecule pro-162 Palmer RM et al. files (ICAM-1, CD44v5, CD44v6) in quitting smokers. European Journal of Clinical Investigation.
    22. (1997). Plasma insulin-like growth factor I and IGF binding protein 3 levels in patients with acute cerebral ischemic injury. Stroke
    23. Plasma levels of insulin-like growth factor-I and lung cancer risk: a casecontrol analysis.
    24. (1990). Regulation and action of insulin-like growth factors at the cellular level.
    25. (2001). Relationships between placental GH concentration and maternal smoking, newborn gender, and maternal leptin: possible implications for birth weight.
    26. (1998). Serum total IGF-1, free IGF-1, and IGFB-1 levels in an elderly population: relation to cardiovascular risk factors and disease. Arteriosclerosis, Thrombosis, and Vascular Biology
    27. (2001). Signalling pathways involved in antiproliferative effects of IGFBP-3: a review. Molecular Pathology
    28. (1996). Soluble adhesion molecules in serum of smokers and nonsmokers, with and without periodontitis.
    29. (2000). The acute influence of tobacco smoking on adhesion molecule expression on monocytes and neutrophils and on circulating adhesion molecule levels in vivo. Addiction Biology
    30. (2001). The contribution of IGF-I to skeletal integrity in postmenopausal women. Clinical Endocrinology
    31. (2001). The growth hormone-insulin-like growth factor-I axis and colorectal cancer. Trends in Molecular Medicine
    32. (1995). The IGF system in metabolism regulation. Diabetes and Metabolism
    33. (2000). The insulin-like growth factor axis: a review of atherosclerosis and restenosis. Circulation Research
    34. (2002). The role of IGF-I in the development of cardiovascular disease in type 2 diabetes mellitus: is prevention possible?
    35. (2001). Validation of smoking status in clinical research into inflammatory periodontal disease.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.